APA (7th ed.) Citation

Turti, T. V., Baibarina, E. N., Degtiareva, E. A., Keshishyan, E. S., Lobzin, Y. V., Namazova-Вaranova, L. S., . . . Notario, G. F. (2012). A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation. BMC research notes, 5(1), 484. https://doi.org/10.1186/1756-0500-5-484

Chicago Style (17th ed.) Citation

Turti, Tatyana V., et al. "A Prospective, Open-label, Non-comparative Study of Palivizumab Prophylaxis in Children at High Risk of Serious Respiratory Syncytial Virus Disease in the Russian Federation." BMC Research Notes 5, no. 1 (2012): 484. https://doi.org/10.1186/1756-0500-5-484.

MLA (9th ed.) Citation

Turti, Tatyana V., et al. "A Prospective, Open-label, Non-comparative Study of Palivizumab Prophylaxis in Children at High Risk of Serious Respiratory Syncytial Virus Disease in the Russian Federation." BMC Research Notes, vol. 5, no. 1, 2012, p. 484, https://doi.org/10.1186/1756-0500-5-484.